Sera Prognostics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US81749D1072
USD
1.99
0.17 (9.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Nutex Health, Inc.
Precipio, Inc.
GeneDx Holdings Corp.
The Joint Corp. (United States)
The Oncology Institute, Inc.
Biodesix, Inc.
Sonida Senior Living, Inc.
Personalis, Inc.
Cano Health, Inc.
Sera Prognostics, Inc.
IMAC Holdings, Inc.

Why is Sera Prognostics, Inc. ?

Icon
Unrated Stock - No Analysis Available
stock-recommendationReal-Time Research Report

Verdict Report

Icon
No Data Found

Is Sera Prognostics, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Sera Prognostics, Inc.
-51.93%
-0.54
138.72%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
-66.17%
EBIT Growth (5y)
-263.52%
EBIT to Interest (avg)
-32.20
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.48
Sales to Capital Employed (avg)
0.00
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
70.56%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
0.97
EV to EBIT
-0.98
EV to EBITDA
-1.00
EV to Capital Employed
0.93
EV to Sales
36.20
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-95.09%
ROE (Latest)
-39.70%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

8What is working for the Company
NET SALES(9M)

At USD 0.07 MM has Grown at 33.96%

PRE-TAX PROFIT(Q)

Highest at USD -7.81 MM

NET PROFIT(Q)

Highest at USD -7.81 MM

EPS(Q)

Highest at USD -0.16

-5What is not working for the Company
NET SALES(HY)

At USD 0.03 MM has Grown at -37.74%

RAW MATERIAL COST(Y)

Grown by 133.95% (YoY

Here's what is working for Sera Prognostics, Inc.

Pre-Tax Profit
Highest at USD -7.81 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (USD MM)

Net Profit
Highest at USD -7.81 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is positive

Net Profit (USD MM)

EPS
Highest at USD -0.16
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Here's what is not working for Sera Prognostics, Inc.

Net Sales
At USD 0.03 MM has Grown at -37.74%
Year on Year (YoY)
MOJO Watch
Near term sales trend is very negative

Net Sales (USD MM)

Raw Material Cost
Grown by 133.95% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales